系统调节器:5-HT系统的潜在机制,以调节阿尔茨海默病的运动改善
Qingxu Wu1, Qiang He1, Xianliang Zhang1
1School of Physical Education, Shandong University, Jinan, Shandong, China.
Aging and disease
|November 5, 2024
概括
定期炼可以通过调节5-西胺 (5-HT) 系统来改善阿尔茨海默病 (AD). 本综述探讨了5-HT在运动诱导的AD缓解中的作用,并提出了新的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 运动生理学 运动生理学
背景情况:
- 阿尔茨海默病 (AD) 是与衰老相关的日益增长的全球健康挑战.
- 5-西胺 (5-HT) 系统是一种神经递质通路,与AD病理和运动反应有关.
研究的目的:
- 通过运动来审查5-HT系统在缓解AD症状中的作用.
- 在AD治疗中探索外围和中央系统之间的5-HT介导交叉通话的潜在机制.
主要方法:
- 文献综述侧重于5-HT系统,运动和阿尔茨海默病.
- 综合生物学对运动原理的分析.
主要成果:
- 5-HT系统影响AD的病理过程,包括Aβ沉积,Tau过酸化和神经炎症.
- 运动显著影响5-HT系统,表明其对AD管理的潜力.
结论:
- 5-HT系统是关键的调解者,通过运动可以缓解AD.
- 了解5-HT介导的交叉通话为阿尔茨海默病提供了新的治疗策略.
相关概念视频
Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449
Adrenergic Agonists: Indirect-Acting Agents
1.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K
Antidepressant Drugs: MAOIs and Other Agents
196
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
196
Role of Neurotransmitters in Memory
452
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
452
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
98
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
98


